Il nostro scopo
Progredire nell'innovazione per una vita migliore
Aree terapeutiche
Scopri di più
Prodotti
Scopri di piùChi siamo
Scopri di più su chi siamo e cosa facciamo per i pazienti.
Stampa
ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY
In 2022, the company has grown 15% in net revenues and has expanded its presence in Portugal and Italy.
To enable further growth and international expansion, ESTE...
17/05/2023
Leggi
ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON’S DISEASE¹
The company has obtained pricing and financing for an inhaled treatment for OFF periods in Parkinson's disease, which it launched on the Spanish market in mid-February 2023. ...
07/03/2023
LeggiLa nostra presenza globale
Ricevi le nostre notizie e uscite media più recenti
Vai